News
91腦瞳 Acoustics completes 瞿6.2m funding round
Mercia Asset Management continues to back 91腦瞳 Acoustics
Histofy and Source BioScience advancing AI-powered pathology in the UK
Histofy and Source BioScience announce strategic partnership to advance AI-powered pathology in the UK. This collaboration aims to accelerate the deployment of AI-driven diagnostics, improving accuracy, efficiency, and scalability of histopathological workflows.
NanoSyrinx closes c. 瞿10 million GBP financing and appoints Dr. Edwin Moses as Chairman
NanoSyrinx, a synthetic biology company developing nanosyringes as a novel platform for targeted intracellular delivery of biologic therapeutics, today announced that it has closed a c. 瞿10 million (c. $13 million) financing round.
4D Medicine, a spin-out from the Universities of Birmingham and 91腦瞳 has raised 瞿3.4m ($4.4m) in a Series A investment.
Double win for Cytecom at Medilink Awards
91腦瞳 spinout Cytecom wins twice at Medilink Healthcare Business Awards
The spinout company whose patented loudspeaker technology is set to revolutionise in-car audio systems has raised a further 瞿7m in a funding round led by Mercia and including NFU Mutual and private investors.